VALOR FOUNDATION INC. addresses the profound, largely preventable physiological and metabolic health decline in OIF/OEF and post-9/11 veterans following military separation—pioneering a measurable, data-driven, holistic health restoration model that integrates modern clinical medicine, advanced nutritional science, evidence-based physical training, clinically supervised recovery technology, and IRB-governed clinical research at the earliest stage of post-deployment decline.
Grounded in the Articles of Incorporation of VALOR FOUNDATION INC., our operational model bridges the gap between acute symptom management and measurable, long-term physiological recovery.
Collaborating on IRB-approved clinical studies, SBIR grants, and VA/NIH research initiatives while facilitating ethical, clinically supervised participation in investigational health optimization protocols under 45 CFR Part 46 and 21 CFR Parts 50 & 56.
REVIEW RESEARCH & IRB ETHICS →
Lab-grounded precision metabolic nutrition education, individualized macronutrient programming, and evidence-based strength and conditioning verified by quarterly DEXA, VO2 max, CGM, HOMA-IR, and comprehensive endocrine/inflammatory panels.
EXPLORE BIOMETRIC TELEMETRY →
Clinically supervised access to cryotherapy, cold-water immersion, red/NIR photobiomodulation, and far-infrared sauna protocols—paired with cohort education and non-partisan policy awareness in St. Augustine, Florida.
VIEW VETERAN COHORT PROGRAMS →More than two million U.S. service members deployed in support of Operation Iraqi Freedom (OIF), Operation Enduring Freedom (OEF), and post-9/11 combat operations. Within years of separation, a disproportionate number experience rapid, multi-system physiological decline that conventional symptom-by-symptom care fails to arrest.
Just as Vietnam-era veterans experienced delayed systemic illness from Agent Orange exposure decades before formal recognition, post-9/11 veterans face a compounding toxic and neuroendocrine burden: open-air burn pit particulates (addressed under the federal PACT Act), repeated blast overpressure and Traumatic Brain Injury (TBI), chronic circadian disruption, and prolonged hypothalamic-pituitary-adrenal (HPA) axis hyperactivation.
Left unaddressed at separation, chronic cortisol dysregulation and systemic inflammation trigger a predictable downstream cascade: suppressed gonadal and thyroid function, visceral fat accumulation, skeletal muscle loss (sarcopenia), insulin resistance, non-alcoholic fatty liver disease (NAFLD), metabolic syndrome, and Type 2 diabetes mellitus (T2DM).
Sustained combat readiness, sleep fragmentation, airborne toxic/burn-pit particulates (PACT Act context), and blast neurotrauma alter baseline neuroendocrine signaling.
Chronic HPA/HPG-axis disruption elevates hs-CRP and IL-6, blunts endogenous hormone output, and impairs cellular recovery capacity.
Impaired glucose disposal, rising HOMA-IR, visceral adiposity, atherogenic dyslipidemia, and loss of lean muscle mass accelerate post-separation decline.
Deploying the 8-Pillar Valor Protocol and quarterly biometric monitoring to measure and restore metabolic, physical, and autonomic health.
Every program operated by VALOR FOUNDATION INC. is explicitly chartered in our Florida Chapter 617 Articles of Incorporation to advance charitable, educational, and scientific outcomes for veterans. Filter the eight program pillars below:
Individualized, biomarker-guided nutritional education and metabolic programming designed to counter post-deployment insulin resistance, visceral adiposity, dyslipidemia, and hepatic steatosis (NAFLD). Programming is anchored to objective blood chemistry, continuous glucose response, and resting metabolic demands rather than generic dietary trends.
Structured, progressive strength, hypertrophy, and cardiopulmonary conditioning protocols engineered for OIF/OEF and post-9/11 veterans. Focused on reversing post-separation sarcopenia, restoring skeletal muscle glucose disposal, improving mitochondrial oxidative capacity, and accommodating blast or orthopedic service injuries.
Clinically supervised access to evidence-informed physiological recovery modalities—including whole-body cryotherapy, cold-water immersion, red and near-infrared (NIR) photobiomodulation, and far-infrared sauna protocols—supporting autonomic nervous system recalibration, HPA-axis down-regulation, and systemic inflammation reduction.
Supporting, co-sponsoring, and collaborating on Institutional Review Board (IRB)-approved clinical studies, Small Business Innovation Research (SBIR) initiatives, and U.S. Department of Veterans Affairs (VA) and National Institutes of Health (NIH) research collaborations—including ethical veteran study recruitment and translational biomarker data synthesis.
Facilitating voluntary veteran participation in structured clinical research investigating peptides, hormonal optimization, and targeted nutritional supplementation—conducted strictly under licensed clinical oversight, documented informed consent, and federal human-subjects protections pursuant to 45 CFR Part 46 (Common Rule) and 21 CFR Parts 50 & 56 (FDA Protection of Human Subjects & IRBs).
Objective, repeatable physiological telemetry tracked at baseline and at least quarterly for core biomarkers—combining DEXA body composition scans, cardiopulmonary VO2 max testing, Continuous Glucose Monitoring (CGM), HOMA-IR insulin resistance scoring, comprehensive endocrine/hormone panels, systemic inflammatory cytokines (hs-CRP, IL-6), and Heart Rate Variability (HRV).
Structured cohort seminars, physiology workshops, and peer-anchored community programming in St. Augustine, Florida. Replaces post-separation isolation with shared mission accountability, health literacy, and family-inclusive education on sleep architecture, stress neurobiology, and metabolic longevity.
Non-partisan public and institutional policy education illuminating the physiological links between combat stress, PACT Act airborne toxic/burn-pit exposures, blast TBI, and early-onset metabolic disease. Conducted strictly within IRC § 501(c)(3) boundaries—with zero political campaign intervention and no substantial legislative lobbying.
Valor Foundation replaces subjective wellness claims with objective, repeatable physiological telemetry tracked at baseline and at least quarterly across core metabolic, cardiopulmonary, endocrine, and inflammatory biomarkers.
| Biomarker / Diagnostic Domain | Specific Clinical & Physiological Metrics | Measurement Cadence | Veteran Restoration Objective |
|---|---|---|---|
| Body Composition & Sarcopenia Index DEXA SCAN |
Dual-Energy X-Ray Absorptiometry (DEXA): Visceral Adipose Tissue (VAT) mass/volume, Appendicular Lean Mass Index (ALMI), total fat-free mass, and bone mineral density (BMD). | AT LEAST QUARTERLY T0, Q1, Q2, Q3, Q4 |
Quantify visceral fat reduction and skeletal muscle restoration countering post-separation sarcopenia and metabolic syndrome. |
| Cardiopulmonary & Mitochondrial Capacity VO2 MAX & RMR |
Direct gas-exchange peak oxygen uptake (VO2 max), ventilatory thresholds (VT1/VT2), substrate oxidation (fat vs. carbohydrate crossover), and Resting Metabolic Rate (RMR). | AT LEAST QUARTERLY T0, Q1, Q2, Q3, Q4 |
Measure cardiopulmonary fitness, burn-pit pulmonary resilience, and cellular aerobic efficiency under Pillar (b). |
| Glycemic Control & Insulin Sensitivity CGM + HOMA-IR |
Continuous Glucose Monitoring (CGM) 14-day ambulatory profiles, fasting plasma glucose, fasting serum insulin, HOMA-IR index, and HbA1c. | QUARTERLY + CONTINUOUS Lab panels quarterly; CGM per cohort phase |
Detect and reverse early-stage insulin resistance, dysglycemia, and Type 2 diabetes mellitus (T2DM) progression under Pillar (a). |
| Neuroendocrine, HPA & Thyroid Axis FULL HORMONE PANEL |
Total & free testosterone, SHBG, estradiol, LH, FSH, diurnal cortisol / DHEA-S (HPA axis), TSH, free T3, free T4, reverse T3, and IGF-1. | AT LEAST QUARTERLY T0, Q1, Q2, Q3, Q4 |
Characterize HPA/HPG-axis disruption and thyroid dysregulation following chronic operational stress and blast TBI exposure. |
| Systemic Inflammation & Cardiometabolic Risk hs-CRP • IL-6 • CMP |
High-sensitivity C-Reactive Protein (hs-CRP), Interleukin-6 (IL-6), homocysteine, ApoB, NMR lipid profile, hepatic enzymes (AST, ALT, GGT for NAFLD), and complete blood count. | AT LEAST QUARTERLY T0, Q1, Q2, Q3, Q4 |
Track resolution of chronic systemic and vascular inflammation associated with toxic exposures and metabolic dysfunction. |
| Autonomic Nervous System & Sleep Telemetry HRV & SLEEP ARCHITECTURE |
Nocturnal Heart Rate Variability (RMSSD), resting heart rate, respiratory rate, sleep latency/efficiency, and validated veteran symptom inventories. | CONTINUOUS + QUARTERLY Daily wearable telemetry; quarterly clinical synthesis |
Quantify parasympathetic recovery and HPA-axis stabilization across Pillar (c) regenerative recovery protocols. |
Pursuant to our Articles of Incorporation, Valor Foundation's educational, physical, recovery, and clinical research programs focus on thirteen interconnected post-deployment physiological domains:
Early-stage impaired fasting glucose, elevated HOMA-IR, and blunted skeletal muscle glucose uptake preceding overt diabetes.
Post-separation metabolic progression toward chronic hyperglycemia, elevated HbA1c, and microvascular/macrovascular risk.
Clustering of central visceral adiposity, elevated triglycerides, reduced HDL-C, elevated blood pressure, and fasting dysglycemia.
Rapid post-deployment accumulation of metabolically active visceral adipose tissue (VAT) despite prior active-duty fitness.
Hepatic steatosis and elevated transaminases driven by chronic hyperinsulinemia, cortisol dysregulation, and toxic exposures.
Elevated ApoB, small dense LDL particles, and hypertriglyceridemia accelerating premature cardiovascular risk in young veterans.
Sustained sympathetic nervous system overdrive and vascular endothelial stiffness elevating resting and ambulatory blood pressure.
Hypogonadism, HPG-axis suppression, subclinical hypothyroidism, and impaired peripheral T4-to-T3 conversion post-deployment.
Chronic hypothalamic-pituitary-adrenal hyperactivation, flattened diurnal cortisol curves, and autonomic exhaustion.
Persistent elevation of hs-CRP, IL-6, and pro-inflammatory cytokines linked to combat trauma, sleep fragmentation, and particulates.
Disproportionate loss of appendicular skeletal muscle mass and strength following orthopedic injury or endocrine suppression.
Airborne hazard and open burn-pit respiratory, cardiopulmonary, and systemic toxic sequelae recognized under the PACT Act.
Neurotrauma, pituitary-hypothalamic blast effects, and post-traumatic stress disorder compounding cardiometabolic decline.
VALOR FOUNDATION INC. is a non-member, board-managed Florida nonprofit corporation headquartered at 1947 A1A S, Suite B, Saint Augustine, FL 32080. All members of the Board of Directors serve without compensation for board service, under strict conflict-of-interest and related-party transaction safeguards.
OIF/OEF Combat Outpost Steel veteran and human performance leader spearheading Valor Foundation's mission to arrest preventable post-deployment physiological decline through objective biomarker tracking and holistic veteran restoration.
Independent Board Director and Corporate Secretary overseeing corporate records, board resolutions, conflict-of-interest disclosures, and institutional governance compliance under Chapter 617, Florida Statutes.
Certified Public Accountant, Independent Board Director, and Corporate Treasurer overseeing nonprofit fund accounting, IRS Form 990 / Section 6104 financial transparency, and independent review of any related-party agreements.